386
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Antihypertensive Medication Adherence and Associated Factors: A Cross-Sectional Analysis of Patients Attending a National Referral Hospital in Asmara, Eritrea

, , ORCID Icon, , &
Pages 2619-2632 | Published online: 23 Nov 2021

References

  • NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in Blood pressure from 1975 to 2015: a pooled analysis of 1479 population – based measurement studies with 19.1 million participants. Lancet. 2017;34:389.
  • Adeloye D, Basquill C. Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis. PLoS One. 2014;9(8):e104300. doi:10.1371/journal.pone.0104300
  • Addo J, Smeeth L, Leon DA. Hypertension in Sub-Saharan Africa: a systematic review. Hypertension. 2007;50:1012–1018. doi:10.1161/HYPERTENSIONAHA.107.093336
  • Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005;112(23):3562–3568. doi:10.1161/CIRCULATIONAHA.105.539569
  • Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005;112:3554–3561. doi:10.1161/CIRCULATIONAHA.105.563452
  • O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112–123. doi:10.1016/S0140-6736(10)60834-3
  • Dzudie A, Rayner B, Ojji D, et al. Roadmap to achieve 25% hypertension control in Africa by 2025. Cardiovasc J Afr. 2017;28(4):261–272. doi:10.5830/CVJA-2017-040
  • Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–450. doi:10.1161/CIRCULATIONAHA.115.018912
  • Campbell NRC, Lemogoum D. Hypertension in sub-Saharan Africa: a massive and increasing health disaster awaiting solution. CVJ Africa. 2015;26(4):152–154.
  • World Health Organization. Adherence to long-term therapies. Evidence for action. Geneva, Switz: World Health Organization; 2003. Available from: http://whqlibdoc.who.int/publications/2003/9241545992.pdf. Accessed October 29, 2021.
  • Gosmanova EO, Kovesdy CP. Adherence to antihypertensive medications: is prescribing the right pills enough? Nephrol Dial Transplant. 2015;30:1649–1656. doi:10.1093/ndt/gfu330
  • Marquart de Terline D, Kramoh KE, Diop IB, et al. Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: cross-sectional study from 12 sub-Saharan countries. Arch Cardiovasc Dis. 2020;113:433–442.
  • World Health Organization. WHO STEPwise approach to surveillance (STEPS). Available from: http://www.who.int/chp/steps/en. Accessed November 10, 2018.
  • Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (Mars) for the psychoses. Schizophr Res. 2000;42(3):241–247. doi:10.1016/s0920-9964(99)00130-9
  • ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC task force for the management of arterial hypertension. J Hypertens. 2013;31:1925–1938.
  • Van de Vijner S, Akinyi H, Oti S, et al. Status report on hypertension in Africa - Consultative review for the 6th Session of the African Union Conference of Ministers of Health on NCD’s. Pan Afr Med J. 2013;16:38. doi:10.11604/pamj.2013.16.38.3100
  • World Health Organization. Disease burden estimates. Geneva:World Health Organisation; 2009.
  • Macquart de Terline D, Kane A, Kramoh KE, et al. Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries. PLoS One. 2019;14(7):e0219266. doi:10.1371/journal.pone.0219266
  • Boima V, Ademola AD, Odusola AO, et al. Factors associated with medication nonadherence among hypertensives in Ghana and Nigeria. Int J Hypertens. 2015;8. doi:10.1155/2015/205716
  • Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine. 2017;96(4):e5641. PMID: 28121920. doi:10.1097/MD.0000000000005641
  • Girma F, Emishaw S, Alemseged F, Mekonnen A. Compliance with anti-hypertensive treatment and associated factors among hypertensive patients on follow-up in Jimma University Specialized Hospital, Jimma, South West Ethiopia: a Quantitative Cross-Sectional Study. J Hypertens. 2014;3:174. doi:10.4172/2167-1095.1000174
  • Abere DA, Getahun AA, Zelalem BM, et al. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health. 2012;12:282. doi:10.1186/1471-2458-12-282
  • Alsolami F, Correa – Velez I, Hou XY. Factors affecting Antihypertensive medications adherence among hypertensive patients in Saudi Arabia. Am J Med Med Sci. 2015;5(4):181–189. doi:10.5923/j.ajmms.20150504.07
  • Esmaeili R, Matlabi M, Khajavi A, Aliasghari E, Sajjadi M. Factors affecting adherence to antihypertensive medication: results from a rural population study in East of Iran. Glob J Health Sci. 2017;9(5):286–291. doi:10.5539/gjhs.v9n5p286
  • Bramley TJ, Gerbino PP, Nightengale BS, et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12:239–245. doi:10.18553/jmcp.2006.12.3.239
  • Nielsen JO, Shrestha AD, Neupane D, Kallestrup P. Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects. J Hum Hypertens. 2017;31(1):14–21. PMID: 27306087. doi:10.1038/jhh.2016.31
  • Gupta P, Patel P, Štrauch B, et al. Risk factors for non-adherence to antihypertensive treatment. Hypertension. 2017;69:1113–1120. doi:10.1161/HYPERTENSIONAHA.116.08729
  • Lowry KP, Dudley TK, Oddone EZ, et al. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother. 2005;39:1198Y1203. doi:10.1345/aph.1E594
  • Al-Ramahi R. Adherence to medications and associated factors: a cross-sectional study among Palestinian hypertensive patients. J Epidemiol Glob Health. 2015;5:125–132. doi:10.1016/j.jegh.2014.05.005
  • Najjuma JN, Breenaman L, Nabirye RC, et al. Adherence to antihypertensive medication: an interview analysis of Southwest Ugandan patients’ perspectives. adherence to antihypertensive medication: an interview analysis of Southwest Ugandan patients’ perspectives. Ann Global Health. 2020;86(1):58, 1–11. doi:10.5334/aogh.2904
  • Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. doi:10.7326/0003-4819-133-1-200007040-00004
  • Bhatia S, Landier W, Hageman L, et al. Systemic exposure to thiopurines and risk of relapse in children with acute lymphoblastic leukemia: a Children’s Oncology Group Study. JAMA Oncol. 2015;1(3):287–295. doi:10.1001/jamaoncol.2015.0245
  • Lo SHS, Chau JPC, Woo JM, Thompson DR, Choi KC. Adherence to antihypertensive medication in older adults with hypertension. J Cardiovasc Nurs. 2016;31(4):296Y303.
  • Nsitou MB, Ikama MS, Drame B, Kaboru BB. Patients-related predictors of poor adherence to antihypertensive treatment in Congo-Brazzaville: a Cross-Sectional Study. Global J Med Public Health. 2013;2:155.
  • Ayodapo AO, Elegbede OT, Omosanya OE, Monsudi KF. Patient education and medication adherence among hypertensives in a tertiary hospital, South Western Nigeria. Ethiop J Health Sci. 2020;30(2):243. doi:10.4314/ejhs.v30.i2.12